Treatment of Central Nervous System Disorders
AssigneeNeuroNova AB
InventorsKioumars Delfani, Ann Marie Janson, H. Georg Kuhn, Karlheinz Plate, Anne Schanzer, Frank-Peter Wachs, Ming Zhao
Life of this patent
Estimating the term…
Abstract
The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells. These methods are useful for reducing at least one symptom of the disorder.
Claims14
A method of alleviating a symptom of a disease or disorder of the nervous system in a patient in need thereof comprising administering VEGF to a neural tissue of said patient in an a therapeutically effective amount sufficient to induce the proliferation or differentiation of, or modulate the survival of, a neural stem cell or neural progenitor cell located in said neural tissue.
Dependencies are inferred from the claim text.